Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Federal Trade Commission
US Army
QuintilesIMS
Healthtrust
Chinese Patent Office
Chubb
Citi
US Department of Justice

Generated: October 21, 2018

DrugPatentWatch Database Preview

Encore Dermat Company Profile

« Back to Dashboard

What is the competitive landscape for ENCORE DERMAT, and what generic alternatives to ENCORE DERMAT drugs are available?

ENCORE DERMAT has one approved drug.

There are three US patents protecting ENCORE DERMAT drugs.

Summary for Encore Dermat
US Patents:3
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Encore Dermat

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Encore Dermat IMPOYZ clobetasol propionate CREAM;TOPICAL 209483-001 Nov 28, 2017 RX Yes Yes 9,956,231 ➤ Sign Up Y ➤ Sign Up
Encore Dermat IMPOYZ clobetasol propionate CREAM;TOPICAL 209483-001 Nov 28, 2017 RX Yes Yes 10,064,875 ➤ Sign Up Y ➤ Sign Up
Encore Dermat IMPOYZ clobetasol propionate CREAM;TOPICAL 209483-001 Nov 28, 2017 RX Yes Yes ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Medtronic
QuintilesIMS
US Department of Justice
Daiichi Sankyo
Merck
Citi
Cerilliant
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.